D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes

Name of the Condition

• Common Name(s): Sarcoidosis of lung with sarcoidosis of lymph nodes
• Medical Term: Sarcoidosis of lung with sarcoidosis of lymph nodes

Summary

Sarcoidosis of lung with sarcoidosis of lymph nodes is a specific manifestation of sarcoidosis, a systemic inflammatory disease, where granulomas (clusters of inflammatory cells) form in both lung tissue and lymph nodes. This condition can cause respiratory symptoms and swollen lymph nodes, though it may also be asymptomatic. Lung and lymph node involvement are common presentations of sarcoidosis.

Causes

The exact cause of sarcoidosis of lung with sarcoidosis of lymph nodes is unknown. It is believed to result from an abnormal immune response to an environmental trigger, such as an infection, allergen, or toxin, in genetically susceptible individuals. The immune system overreacts, leading to chronic inflammation and granuloma formation in the lungs and lymph nodes.

Risk Factors

• Age: Most commonly diagnosed in individuals between 20 and 40 years old.
• Ethnicity: Higher prevalence in African-American and Northern European populations.
• Family History: A family history of sarcoidosis may increase risk.
• Gender: Slightly more common in females.

Symptoms

• Persistent dry cough and shortness of breath (if lungs are involved).
• Swollen lymph nodes, particularly in the chest or neck.
• Fatigue and general malaise.
• Chest discomfort or pain.
• In some cases, no symptoms (asymptomatic).

Diagnosis

Diagnosis typically involves a combination of clinical evaluation, imaging (e.g., chest X-ray or CT scan), and biopsy of affected tissue (e.g., lung or lymph node) to confirm granuloma formation. Laboratory tests may also assess organ function and rule out other conditions.

Treatment Options

Treatment depends on symptom severity and organ involvement. Mild cases may not require therapy, while moderate to severe cases may involve corticosteroids (e.g., prednisone) to reduce inflammation. Other medications, such as immunosuppressants, may be used for refractory cases. Regular monitoring is essential to manage symptoms and prevent complications.

Prognosis and Follow-Up

Prognosis varies; many individuals experience mild or no symptoms and may not require long-term treatment. However, some may develop chronic symptoms or organ damage. Regular follow-up with a healthcare provider is important to monitor lung function, lymph node status, and overall health.

Complications

Potential complications include progressive lung damage, respiratory failure, or involvement of other organs (e.g., heart, eyes, skin). Chronic inflammation may also lead to scarring (fibrosis) in the lungs or lymph nodes.

Lifestyle & Prevention

No specific prevention methods exist, but maintaining overall health (e.g., avoiding smoking, managing stress) may support immune function. Regular medical check-ups are recommended for early detection of changes in symptoms or organ function.

When to Seek Professional Help

Seek medical attention if you experience persistent respiratory symptoms (e.g., worsening cough, shortness of breath), unexplained swollen lymph nodes, or other systemic signs (e.g., fatigue, fever) that do not improve.

Tips for Medical Coders

When coding D86.2, ensure documentation specifies both lung and lymph node involvement. Verify that the diagnosis aligns with clinical findings (e.g., imaging, biopsy) to support the combination of organ systems affected. Accurate documentation of the specific sites (lung and lymph nodes) is critical for correct code assignment.